Major metabolite of glucose-dependent insulinotropic polypeptide (GIP), GIP(3-42), acts as a GIP receptor antagonist in vivo.

Victor Gault, JC Parker, P Harriott, MH Mooney, Peter Flatt, Finbarr O'Harte

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)36-36
JournalDiabetic medicine
Volume20 (S2
Publication statusPublished - 2003

Cite this